Skip to main content
. 2021 Mar 19;22(6):3145. doi: 10.3390/ijms22063145

Table 2.

Change in Echocardiographic Parameters after each Treatment.

n= After 1st Rx After 2nd Rx After 3rd Rx
Δ EDV (µL)
Vehicle 18 4.0 ± 1.4 2.1± 0.6 2.1 ± 1.4
Combined dose 18 −0.1 ± 1.5 1.7 ± 1.7 −0.2 ± 1.6
Multiple doses 16 −2.1 ± 1.7 # 0.6 ± 2.2 3.5 ± 2.0
Δ ESV (µL)
Vehicle 18 3.6 ± 1.0 1.8 ± 0.4 1.9 ± 1.0
Combined dose 18 −3.3 ± 1.0 # 0.6 ± 1.4 −0.1 ± 1.3
Multiple doses 16 −4.3 ± 1.3 # −0.4 ± 1.8 0.5 ± 1.4
Δ SV (µL)
Vehicle 18 0.5 ± 0.4 0.3 ± 0.2 0.1 ± 0.4
Combined dose 18 3.4 ± 0.6 # 1.1 ± 0.7 −0.1 ± 0.5
Multiple doses 16 2.4 ± 0.6 # 0.8 ± 0.8 3.0 ± 0.9 †,§
Δ EF (%)
Vehicle 18 −0.8 ± 0.2 −0.3 ± 0.1 −0.5 ± 0.1
Combined dose 18 4.1 ± 0.5 # 0.7 ± 0.8 0.1 ± 0.5
Multiple doses 16 3.7 ± 0.6 # 0.8 ± 0.6 2.0 ± 0.5 †,§

Rx indicates treatment; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction. To distinguish from the group assignment, these four major parameters EDV, ESV, SV, and EF are bold and underlined. We present the absolute value of the changes after each treatment of these four major underlined parameters in this table. # p < 0.05 vs. Vehicle 1st Rx, p < 0.05 vs. Vehicle 3rd Rx, § p < 0.05 vs. Combined dose 3rd Rx. All data are represented as the mean ± SEM.